Amneal Pharmaceuticals (AMRX) Shares Outstanding (2017 - 2026)

Amneal Pharmaceuticals has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $319.4 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.68% year-over-year to $319.4 million in Q2 2026; TTM through Jun 2026 was $319.4 million, a 1.68% increase from a year earlier, with the FY2025 full-year figure at $314.6 million, up 1.5% from the prior year.
• Shares Outstanding (Entity) was $319.4 million for Q2 2026 at Amneal Pharmaceuticals, roughly flat from $319.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $319.4 million in Q2 2026, with the low at $302.9 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $309.5 million, with a median of $309.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) advanced 0.68% in 2022, then gained 1.79% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $303.6 million in 2022, then gained by 0.94% to $306.5 million in 2023, then rose by 1.14% to $310.0 million in 2024, then gained by 1.5% to $314.6 million in 2025, then advanced by 1.5% to $319.4 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $319.4 million (Q2 2026), $319.0 million (Q1 2026), and $314.6 million (Q4 2025), per Business Quant data.